54 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25922179	10	Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors.	Csir-Indian Institute of Chemical Technology
24980116	3	Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers.	Csir-Indian Institute of Chemical Technology
24900839	24	Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes.	Vanderbilt University Department of Chemistry
23777825	7	Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors.	Csir-Indian Institute of Chemical Technology
8544178	46	New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.	Ciba-Geigy
8021921	28	Dual angiotensin converting enzyme/thromboxane synthase inhibitors.	Ciba-Geigy
1995891	9	Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships.	Institut De Chimie Des Substances Naturelles
2160536	13	Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives.	Rorer Central Research
2120440	23	Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.	Kissei Pharmaceutical
2153207	31	Phosphoramidate peptide inhibitors of human skin fibroblast collagenase.	University of Kentucky
2836590	5	Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.	Squibb Institute For Medical Research
2832605	2	Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.	Schering-Plough
3339612	9	Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives.	Sankyo
3531517	17	Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues.	TBA
2983075	24	Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids.	TBA
2999395	30	Angiotensin converting enzyme inhibitors: N-substituted D-glutamic acid gamma dipeptides.	TBA
3906126	10	Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors.	TBA
2995669	11	Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme.	TBA
2981324	71	Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives.	TBA
6330355	9	Bicyclic lactam inhibitors of angiotensin converting enzyme.	TBA
6310113	29	Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.	TBA
6310112	64	Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.	TBA
9873498	4	Probing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity.	Universit£
	38	Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase	TBA
	6	Novel angiotensin converting enzyme inhibitors containing -hydroxy ketomethylene dipeptide isosteres	TBA
	46	Mercaptoacyl dipeptides as dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Preliminary structure-activity studies	TBA
	5	A new potent inhibitor for angiotensin converting enzyme: (R,S)-captopril-F3	TBA
21782455	16	Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors.	India Institute of Chemical Technology
21621881	30	Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation.	Zhejiang University
20167484	24	The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives.	University of Calabria
8904845	3	Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus.	Searle Research and Development
	1	K-13 and of4949: Evaluation of key partial structures and pharmacophore delineation	TBA
	1	Acid-catalyzed O-allylation of β-hydroxy-α-amino acids: an entry into conformationally constrained dipeptide surrogates	TBA
16784850	14	Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.	University of Cape Town
15125946	9	Silanediol peptidomimetics. Evaluation of four diastereomeric ACE inhibitors.	State University of New York
10698448	24	N-formyl hydroxylamine containing dipeptides: generation of a new class of vasopeptidase inhibitors.	Bristol-Myers Squibb Pharmaceutical Research Institute
9925736	16	Vasopeptidase inhibitors: incorporation of geminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides.	The Bristol-Myers Squibb Pharmaceutical Research Institute
8558518	38	Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.	Bristol-Myers Squibb Pharmaceutical Research Institute
8496905	6	Synthesis and analgesic effects of N-[3-[(hydroxyamino) carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymes.	Ccipe-Faculté
25300819	5	Synthesis and evaluation of novel triazoles and mannich bases functionalized 1,4-dihydropyridine as angiotensin converting enzyme (ACE) inhibitors.	Csir-Indian Institute of Chemical Technology
8360888	14	Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11.	Marion Merrell Dow Research Institute
8254612	10	Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors.	Ciba-Geigy
8057292	83	Mercaptoacyl amino acid inhibitors of atriopeptidase. 1. Structure-activity relationship studies of methionine and S-alkylcysteine derivatives.	Schering-Plough Research Institute
7837244	33	Non-peptidic inhibitors of human leukocyte elastase. 4. Design, synthesis, and in vitro and in vivo activity of a series of beta-carbolinone-containing trifluoromethyl ketones.	Zeneca Pharmaceuticals
3669006	10	Angiotensin-converting enzyme inhibitors: perhydro-1,4-thiazepin-5-one derivatives.	Sankyo
29039662	62	Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.	Csir-National Chemical Laboratory
3009814	15	Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity.	TBA
2995664	19	N alpha-(diphenoxyphosphoryl)-L-alanyl-L-proline, N alpha-[bis (4-nitrophenoxy)phosphoryl]-L-alanyl-L-proline, and N alpha-[ (2-phenylethyl)phenoxyphosphoryl]-L-alanyl-L-proline: releasers of potent inhibitors of angiotensin converting enzyme at physiological pH and temperature.	TBA
1738153	45	A novel class of enkephalinase inhibitors containing a C-terminal sulfo group.	Dainippon Pharmaceutical